1.) option contracts - these will only be issued IF z160 phase II turns out to be successful.. mgmt playing it safe
2.) RS is typically a terrible thing for a company despite what other YMB members state... once they RS this opens the door for ZLCS to issue the S-3 and start diluting AGAIN
3.) they don't plan to have the PPS over $1 by september/october which tells me:
- Z944 is garbage
- no renewal of partnerships
- they are lost with FOV1101 and this will kept swept under the rug
as others have mentioned.. it's officially a one trick pony with Z160 and mgmt has set themselves up with the option to make a lot of coin if successful
Gar: Most of the time were on similar wave lengths, not this time amigo. I think they are only looking at the RS for listing purposes. Remember that management takes the biggest hit with greater dilution. Additionally why would they keep the ball rolling if Z-160 and Z-944 were failing? JMHO
Jim Long and calm
Sentiment: Strong Buy
I appreciate your opinion, Garrett-I believe you call em as you see them. I like rs's "haha"!
Number 1--important to get Novartis renewed-if not--well, you know....
Agree with you about r/s generally speaking